ScanSource Lowers Full-Year Sales and EBITDA Guidance Despite Q2 Revenue Growth

summarizeSummary

ScanSource reported mixed Q2 FY26 results and significantly lowered its full fiscal year 2026 guidance for net sales and Adjusted EBITDA, indicating a more challenging outlook.

check_boxKey Events

• Q2 FY26 Financial Results

  Reported net sales of $766.5 million (+2.5% year-over-year) and GAAP diluted EPS of $0.75 (+7.1% year-over-year). However, Adjusted EBITDA declined by 11.6% to $31.2 million, and non-GAAP diluted EPS decreased by 5.9% to $0.80.

• Lowered FY26 Annual Net Sales Guidance

  Updated full fiscal year 2026 net sales guidance to $3.0 billion to $3.1 billion, down from the prior outlook of $3.1 billion to $3.3 billion.

• Lowered FY26 Annual Adjusted EBITDA Guidance

  Revised full fiscal year 2026 Adjusted EBITDA guidance to $140 million to $150 million, a reduction from the previous range of $150 million to $160 million.

• Board Committee Reassignments

  Charles A. Mathis was appointed Lead Independent Director and Chair of the Nominating and Corporate Governance Committee, succeeding Peter C. Browning, who remains an independent director. Vernon J. Nagel succeeded Mr. Mathis as Chair of the Audit Committee.

auto_awesomeAnalysis

ScanSource reported mixed second-quarter results, with GAAP diluted EPS increasing year-over-year, but non-GAAP profitability metrics like Adjusted EBITDA and non-GAAP diluted EPS declining. The most significant market-moving information is the company's decision to lower its full fiscal year 2026 guidance for both net sales and Adjusted EBITDA. This downward revision signals potential headwinds or a more cautious outlook for the remainder of the fiscal year, which could pressure investor sentiment. The board committee reassignments are routine and have minimal market impact.